MO SB 1024
died on adjournmentSB 1024 - This act requires practitioners, before an initial opioid prescription and the third in a course of treatment, to consult with the patient as to the risks of taking opioids and alternatives to opioids. The practitioner shall make note of the consultation in the patient's medical record. The provisions of this act shall not apply to those in hospice or palliative care, in a long-term care facility, or receiving treatment for cancer, substance abuse, or opioid dependence. This act is identical to SB 17 (2025), SB 943 (2024), and SB 673 (2023) and substantially similar to a provision in SS/SB 830 (2024). SARAH HASKINS
Missouri · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did MO SB 1024 pass?
No. MO SB 1024 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-04-08): Hearing Conducted S Families, Seniors and Health Committee
What is MO SB 1024 about?
MO SB 1024 is a bill in the 2026 Regular Session titled “SB 1024 - This act requires practitioners, before an initial opioid prescription and the third in a course of treatment, to consult with the patient as to the risks of taking opioids and alternatives to opioids. The practitioner shall make note of the consultation in the patient's medical record. The provisions of this act shall not apply to those in hospice or palliative care, in a long-term care facility, or receiving treatment for cancer, substance abuse, or opioid dependence. This act is identical to SB 17 (2025), SB 943 (2024), and SB 673 (2023) and substantially similar to a provision in SS/SB 830 (2024). SARAH HASKINS”.
Who sponsors MO SB 1024?
May, Karla is the primary sponsor of MO SB 1024.
Description
SB 1024 - This act requires practitioners, before an initial opioid prescription and the third in a course of treatment, to consult with the patient as to the risks of taking opioids and alternatives to opioids. The practitioner shall make note of the consultation in the patient's medical record. The provisions of this act shall not apply to those in hospice or palliative care, in a long-term care facility, or receiving treatment for cancer, substance abuse, or opioid dependence. This act is identical to SB 17 (2025), SB 943 (2024), and SB 673 (2023) and substantially similar to a provision in SS/SB 830 (2024). SARAH HASKINS
- Introduced
- —
- Latest action
- 2026-04-08 — Hearing Conducted S Families, Seniors and Health Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- May, Karlaprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-04-08
Hearing Conducted S Families, Seniors and Health Committee
2026-04-01
Hearing Cancelled S Families, Seniors and Health Committee
2026-01-15
Second Read and Referred S Families, Seniors and Health Committee
reading-2,referral-committee
2026-01-07
S First Read
reading-1
2025-12-01
Prefiled
Versions
- 4400S.01I - IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:25:15.077812Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MO&identifier=SB 1024. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.